Navigation Links
Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
Date:12/2/2007

p>This news release and any oral statements made with respect to the information contained in this news release, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements which express plans, anticipation, intent, contingency, goals, targets, future development and are otherwise not statements of historical fact. These statements are based on EpiCept's current expectations and are subject to risks and uncertainties that could cause actual results or developments to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Factors that may cause actual results or developments to differ materially include: the risk that our NP-1 clinical trials will not be successful, that NP-1 will not receive regulatory approval or achieve significant commercial success, the risk that Ceplene will not receive regulatory approval or marketing authorization in the EU or that Ceplene, if approved, will not achieve significant commercial success, the risk that Myriad's development of Azixa(TM) will not be successful, the risk that Azixa will not receive regulatory approval or achieve significant commercial success, the risk that we will not receive any significant payments under our agreement with Myriad, the risk that the development of our other apoptosis product candidates will not be successful, the risk that our ASAP technology will not yield any successful product candidates, the risk that clinical trials for EPC 2407 will not be successful, that EPC 2407 will not receive regulatory approval or achieve significant commercial success, the risk that our other product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later stage clinical trials, the risk that EpiCept will not obtain approval to market any of its product candi
'/>"/>
SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... (PRWEB) August 30, 2014 Insomnia causes disturbances ... listeners understand how they unknowingly developed insomnia and the steps ... nights during. Tune in to the show at this ... show airs live on August 30, and will be podcasted ... on programming, go to DrCarolFrancisTalkRadio.com. , "Insomnia causes ...
(Date:8/30/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... broken bones or other orthopedic trauma shops around for additional ... patients and patients who had used narcotic painkillers previously were ... lead author Dr. Brent Morris, a shoulder and neck surgeon ... doctors aren,t talking to one another about the painkiller needs ...
(Date:8/30/2014)... 2014 Hastings and Hastings, a qualified ... throughout Arizona is pleased to report having saved a ... example among many cases where Hastings and Hastings has ... retain a greater portion of their settlement or recovery. ... a positive solution for Arizona car accident victims is ...
(Date:8/30/2014)... a plant-based medication commonly used to treat gout, ... in reducing potential complications from this type of ... gastrointestinal adverse effects, according to a study published ... released early online to coincide with its presentation ... Common complications after cardiac surgery include postpericardiotomy syndrome ...
(Date:8/30/2014)... PA (PRWEB) August 30, 2014 "My ... sleep knowing that, at any moment, her fever might ... order to keep me well aware of how she ... developed the TEMP ALARM to continuously monitor a child's ... develops a fever. This ensures that prompt medical care ...
Breaking Medicine News(10 mins):Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2
... Earnings Per Share of $0.032008 Nexavar Net Sales of $678 ... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... quarter 2008. For the full year, Onyx recorded net ... with a net loss of $34.2 million, or $0.67 per ...
... (OTC Bulletin Board: EFSF) an emerging healthcare consumer products ... nutraceutical products, today announced that Martin Schmieg, current President ... CEO of eFoodSafety.com, has purchased stock in the open ... shares in the open market on February 23, 2009, ...
... VERNON, Wash., and LINCOLN, Neb., Feb. 23 ... leader in risk and disease analytic software designed ... oral disease, today announced a cooperation agreement with ... provider of dental practice management software running on ...
... , Inc. announced today that,Daniel P. Amos, Chairman and ... of $2.8 million that he earned based on achievement ... proposal,recognizing that, although Aflac delivered a strong operating performance ... price given the current,turbulence in the stock markets. , ...
... intake of calcium appear to have a lower risk of ... intakes have lower risks of colorectal cancer and other cancers ... February 23 issue of Archives of Internal Medicine , ... known to benefit bone health, according to background information in ...
... PARK, N.C., Feb. 23 The Clearinghouse on Male ... was launched today. The Web site is designed to ... male circumcision in HIV prevention. The Clearinghouse was initiated ... Nations Programme on HIV/AIDS (UNAIDS), the AIDS Vaccine Advocacy ...
Cached Medicine News:Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 2Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 3Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 4Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 5Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 6Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 7Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 8Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 9Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 10Health News:eFoodSafety.com Announces Open Market Stock Purchase by Management 2Health News:PreViser Corporation and MacPractice Announce Cooperation Agreement 2Health News:Aflac Chairman & CEO Will Forgo 2008 Bonus of $2.8 Million 2Health News:Calcium associated with lower risk of cancer in women 2Health News:Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched 2Health News:Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched 3Health News:Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched 4Health News:Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched 5
(Date:8/29/2014)... 29, 2014 Does your doctor know what you,re ... have recommended marijuana to the over 112,000 currently registered patients ... majority of the other roughly 20,300+ active physicians listed with ... about it – even though a poll in February 2014 ... they have tried it. "With marijuana legalization ...
(Date:8/29/2014)... 2014 Diseases largely eradicated in ... returning. Measles was declared eliminated in 2000, yet the ... August 15—the highest incidence in 20 years. In July, ... whooping cough a problem of "epidemic proportions." ... dying from these preventable diseases—in part because some parents ...
(Date:8/29/2014)... Calif. , Aug. 29, 2014  Abaxis, Inc. ... manufacturing point-of-care blood instrumentation and consumables to the medical, ... Severson , Chairman and Chief Executive Officer, will present ... Ideas Conference 2014 on Tuesday, September 9, 2014 at ... the Omni Berkshire Place Hotel in New ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... RICHMOND, Virginia and ROSH HA,AYIN, Israel, December 22 ... wound management, announced today that it successfully completed its,latest round ... by Eli Gilboa,CPA, of Gilboa & Licht, who serves as ... To date, the company has raised a total,US$10 million. Proceeds ...
... , , SUNNYVALE, Calif., Dec. 22 Arrayit Corporation ... leader, today announced that the Company has made a technological ... its proprietary microarrays, which are tiny glass substrates that contain ... and molecular diagnostics. The advance allows highly precise printing of ...
Cached Medicine Technology:EnzySurge, Maker of DermaStream(R) Secures US$2.5 Million in Private Capital 2Arrayit Corporation Announces Manufacturing Breakthrough 2Arrayit Corporation Announces Manufacturing Breakthrough 3
The Surgifresh mini has the same rugged construction as the Plume-inator. It is the ideal size for operating room, clinic and office settings. This unit includes a filter test button, hospital grade ...
... ESU devices. Suitable for use in Dr.'s ... ,The FreshAire filter technology is ... performance, offering the clinician unparalleled plume capture ... ,Quiet, compact, economical. The VersaVac2® is the ...
... Smoke Evacuation System provides a more intelligent ... surgical plume. This next generation smoke ... feedback with numerous user requested features and ... flow control can be adjusted to ten ...
... VitalVac's advanced technology makes ... to evacuate surgical plume. ... O.R. environment is "smoke-free", ... staff safe from potentially ...
Medicine Products: